Nectar Clinical Trial, 1211 Medical Center Drive, Nashville, TN (2026)

NECTAR is a nationwide research study for people who are hospitalized with COVID-19. We want to see if these drugs help you get better by preventing or treating lung damage caused by COVID. Why is this study important? People are still becoming sick and hospitalized with COVID-19 and new treatments are needed to help fight the virus. Older adults, rural residents, those with other health conditions, and racially and ethnically diverse groups are more likely to be infected, hospitalized, or die from COVID-19. It is important to find out if these new drugs help people get better from COVID-19, especially those impacted the most. Joining the NECTAR Study is voluntary. If you join, you can leave the study at any time.

09/13/2021

The NECTAR study is testing new drugs that may help people recover from COVID-19 and prevent serious complications. Learn more at nectarstudy.org

08/02/2021

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

The new trial has enrolled its first patient.

Part of the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) initiative, the ACTIV-4 Host Tissue trial will first explore the efficacy of drugs that target the Renin Angiotensin Aldosterone System (RAAS) and the immune system, both of which become dysregulated during COVID-19 and cause widespread damage in patients infected with the SARS-CoV-2 virus.

The virus that causes COVID-19 is known to target and disrupt the RAAS and immune system, resulting in a biological imbalance triggering a cascade of potentially life-threatening complications, including blood vessel damage, lung damage, blood clots, and heart injury.

Vanderbilt University Medical Center researchers, supported by the National Institutes of Health (NIH), are leading a nationwide clinical trial to explore the safety and effectiveness of a group of novel drugs designed to protect patients hospitalized with COVID-19 at high risk of poor outcomes.

Address

1211 Medical Center Drive
Nashville, TN
37232

Telephone

+16153438010

Website

https://nectarstudy.org/

Alerts

Be the first to know and let us send you an email when Nectar Clinical Trial posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Nectar Clinical Trial:

Nectar Clinical Trial